Aortic Aneurysm Market Driven by Advancements in EVAR and TEVAR, Persisstence Market Research Finds

The global healthcare landscape is undergoing rapid transformation, with cardiovascular diseases continuing to remain one of the foremost causes of morbidity and mortality worldwide. Within this spectrum, aortic aneurysms (AA)-abnormal bulging of the aorta characterized by a dangerous weakening of the arterial wall-represent one of the most life-threatening vascular disorders. The rising aging population, increased prevalence of lifestyle disorders, expansion of minimally invasive vascular treatment technologies, and growing awareness of early screening programs have collectively strengthened the demand for advanced aortic aneurysm treatment solutions. Against this backdrop, the global aortic aneurysm market, valued at US$ 3.34 billion in 2022, is anticipated to reach US$ 9.93 billion by 2032, growing at an impressive 11% CAGR during the forecast period.

Download Your Free Sample & Explore Key Insights: https://www.persistencemarketresearch.com/samples/33177

Overview of the Aortic Aneurysm Market

The aortic aneurysm market has evolved considerably over the past decade, driven by improved diagnostic procedures, the development of next-generation stent grafts, and the shift from open surgeries to minimally invasive approaches. Increasing clinical initiatives for early detection, a rise in comorbid conditions including hypertension and atherosclerosis, and expanding reimbursement support, particularly in developed economies, are pushing the market forward. Furthermore, growing patient preference toward procedures with shorter hospitalization and recovery time has made technologies such as endovascular aneurysm repair (EVAR) and thoracic endovascular aneurysm repair (TEVAR) more widely adopted.

Statistically, the market has shown consistent year-on-year expansion. The industry built on its US$ 3 billion valuation in 2021 to reach US$ 3.34 billion in 2022, indicating robust demand for both treatment technologies and diagnostic tools. The dominant market segment remains abdominal aortic aneurysm (AAA), accounting for over 70% of the market share, driven primarily by the high incidence rate among individuals aged 65 and above. Geographically, North America leads the global market with approximately 47% share, owing to superior access to advanced healthcare facilities, high adoption of minimally invasive treatments, and strong government support for screening initiatives such as the SAVE Act in the United States.

The cumulative impact of chronic disease burden, an expanding geriatric population base, and technological innovations positions the aortic aneurysm market as one of the most promising and steadily advancing segments of the cardiovascular treatment landscape.

Key Highlights from the Report

• The global aortic aneurysm market is projected to reach US$ 9.93 billion by 2032.
• Market growth is driven by the rising prevalence of atherosclerosis and lifestyle-induced cardiovascular diseases.
• Abdominal aortic aneurysm (AAA) remains the leading segment with more than 70% market share.
• Endovascular aneurysm repair (EVAR) accounts for nearly 70% of total procedures performed.
• North America dominates the market with a 47% share due to strong reimbursement support.
• Technologies supporting minimally invasive surgeries continue to reshape treatment approaches.

Market Segmentation

Market segmentation for aortic aneurysm products and treatments can be broadly categorized by type of aneurysm, product type, treatment method, and end-user. By aneurysm type, the market is dominated by abdominal aortic aneurysms (AAA) due to their significantly higher prevalence in the elderly population. AAAs most commonly occur in the infrarenal region and are more frequently detected through routine abdominal imaging. AAA remains the primary focus of surgical interventions and R&D activities, supported by substantial government initiatives aimed at early screening. In contrast, thoracic aortic aneurysms (TAA) represent a smaller but steadily growing segment, largely due to increased acceptance of minimally invasive TEVAR procedures and ongoing technological advancements that are gradually improving clinical outcomes.

By product type, the market is segmented into stent grafts and catheters, with stent grafts accounting for a dominant share of the market-approximately 85% in 2022. The stent graft landscape has undergone major innovation with the development of advanced systems incorporating enhanced imaging and polymer-based technology. These devices, such as the Nellix and Ovation systems, enable precise deployment and better postoperative monitoring capabilities, thus improving long-term patient outcomes. Catheters, while essential to the procedure, represent a supportive segment that complements stent graft adoption.

By treatment method, the market is divided into Open Surgical Repair (OSR) and Endovascular Aneurysm Repair (EVAR). EVAR has emerged as the gold-standard treatment approach in many countries, representing nearly 75% of all aneurysm repair procedures performed in the U.S. alone. Its advantages-reduced surgical trauma, minimal scarring, shorter hospital stays, and faster recovery-have made it the preferred method for both clinicians and patients. OSR remains relevant, particularly for anatomically unfavorable cases, complex thoracic aortic aneurysms, or in emerging economies where advanced stent graft systems are less accessible. The continued use of OSR is largely influenced by its lower cost and broader availability in regions where endovascular devices remain cost-prohibitive.

By end-user, hospitals remain the dominant segment, accounting for nearly 75% of the market. Hospitals provide an extensive infrastructure enabling management of complex aneurysm cases, making them the preferred choice among vascular surgeons. Many major industry players channel their distribution efforts toward hospital networks to ensure widespread adoption of their products. Meanwhile, ambulatory surgery centers (ASCs) are gaining traction due to their cost-efficiency and shorter procedure times, making them increasingly appealing for EVAR procedures in developed healthcare markets.

Read Detailed Analysis: https://www.persistencemarketresearch.com/market-research/aortic-aneurysm-market.asp

Regional Insights

Regional trends within the aortic aneurysm market reflect a blend of demographic patterns, technological maturity, healthcare infrastructure, and reimbursement landscapes. North America, led by the United States, holds the largest market share at approximately 47%. The region benefits from robust screening programs, high prevalence of cardiovascular disease risk factors, and rapid adoption of minimally invasive interventions. Government-backed policies such as Medicare coverage for abdominal aortic ultrasound encourage early detection, further driving treatment demand.

In Europe, the market continues to thrive due to a high incidence of atherosclerosis, strong public health screening programs, and rapid integration of advanced stent graft technologies. Nations such as the U.K., Germany, and France have well-established vascular care protocols and population-level screening programs that contribute significantly to early aneurysm diagnosis. The presence of the NHS screening initiative plays a particularly influential role in increasing the rate of elective aneurysm repair, thereby strengthening market expansion.

Asia Pacific represents the fastest-growing region, fueled by its rapidly aging population and rising prevalence of hypertension and cardiovascular disease. Countries such as China, Japan, and India are witnessing a sharp surge in demand for minimally invasive vascular treatments. Economic development, growing healthcare expenditure, and expanding medical tourism sectors have significantly improved access to advanced aneurysm repair technologies. The elderly population in the region is expected to triple between 2010 and 2050, creating massive demand for aneurysm diagnosis and treatment services. As a result, Asia Pacific accounts for 24% of the global market share and is projected to grow rapidly over the next decade.

Market Drivers

Market growth is powered primarily by the increasing prevalence of risk factors such as atherosclerosis, hypertension, obesity, and smoking, which predispose individuals to aortic aneurysm formation. The global rise in the geriatric population-which is notably more susceptible to aortic wall degeneration-remains a major catalyst behind the market's acceleration. For example, the number of adults aged 65 and above in the U.S. alone is projected to reach nearly 95 million by 2060, dramatically increasing the patient pool requiring AAA or TAA treatment.

Lifestyle-related risk factors also play a crucial role. Smoking, in particular, contributes significantly to aneurysm development and progression, with global tobacco usage affecting more than 22% of the population. Continuous smoking increases the risk of aneurysm expansion and rupture, necessitating timely intervention. Additionally, strong adoption of minimally invasive surgical techniques, favorable reimbursement policies, advancements in stent graft systems, and an increasing volume of research into polymer-based graft technologies are collectively propelling the market forward.

Market Restraints

Despite its growth trajectory, the market faces notable restraints. Lack of awareness regarding aortic aneurysms remains a major barrier, as many cases remain asymptomatic until rupture, often leading to fatal outcomes. High treatment costs and limited access to advanced aneurysm repair technologies in low- and middle-income regions also impede growth. Certain complications associated with aneurysm repair procedures-including endoleaks, stent stenosis, and iliac perforation-pose challenges and may discourage adoption of endovascular techniques.

Additionally, technological shortcomings in current stent graft systems, particularly concerning durability and long-term performance in complex anatomies, continue to limit broader market penetration. While research is underway to improve outcomes, achieving consistent success remains an ongoing challenge for manufacturers and clinicians.

Market Opportunities

The emergence of minimally invasive endovascular procedures represents the greatest opportunity for market players. These procedures dramatically reduce the risks and recovery time associated with traditional open surgeries. Continued innovation in stent graft design-such as fenestrated grafts, branched devices, and polymer-based sealing systems-offers substantial avenues for expansion. Increasing adoption of imaging-guided surgical technologies and AI-assisted vascular diagnostics is expected to further enhance treatment precision and demand.

Emerging economies, particularly in Asia Pacific and Latin America, present untapped opportunities due to improving healthcare infrastructure and growing awareness of early aneurysm screening and treatment. The increasing use of advanced grafts in thoracic aneurysm repair, combined with supportive government initiatives and rising healthcare investment, is expected to open new growth channels throughout the forecast period.

Get Custom Insights Designed for Your Business: https://www.persistencemarketresearch.com/request-customization/33177

Company Insights

• Medtronic
• Endologix LLC
• Gore Medical
• MicroPort Scientific Corporation
• Cook
• JOTEC
• Cardinal Health
• Terumo Corporation
• Lombard Medical
• AbbVie Inc

Key Segments Profiled in the Aortic Aneurysm Industry Survey

Aortic Aneurysm by Type

Aortic Aneurysm by Thoracic Aortic Aneurysm (TAA)
Aortic Aneurysm by Abdominal Aortic Aneurysm (AAA)

Aortic Aneurysm Treatment

Aortic Aneurysm by Open Surgical Repair (OSR)
Aortic Aneurysm by Endovascular Aneurysm Repair (EVAR)

Aortic Aneurysm Product

Aortic Aneurysm by Stent Grafts
Aortic Aneurysm by Catheters

Aortic Aneurysm End User

Aortic Aneurysm by Hospitals
Aortic Aneurysm by Ambulatory Surgery Centers
Aortic Aneurysm by Clinics

Aortic Aneurysm Region

North America Aortic Aneurysm Market
Latin America Aortic Aneurysm Market
Europe Aortic Aneurysm Market
Asia Pacific Aortic Aneurysm Market
Middle East & Africa Aortic Aneurysm Market

Recent Developments:

Cook Medical, Inc. received U.S. FDA Breakthrough Device Designation in 2021 for its Zenith Fenestrated+ Endovascular Graft (ZFEN+), designed to treat complex intravascular aortic aneurysms.

Endologix LLC expanded its global footprint through increased EVAR product distribution across the U.S., Canada, Europe, South Korea, and New Zealand, enhancing its international market presence.

Conclusion

The aortic aneurysm market is poised for sustained growth as demographic shifts, technological innovation, and rising awareness converge to transform the treatment landscape. Dominated by abdominal aortic aneurysm cases and driven by the global preference for minimally invasive surgical options, the market continues to innovate rapidly. Regions such as North America and Europe lead in technology adoption and screening initiatives, while Asia Pacific emerges as a high-growth region fueled by its expanding elderly population. As industry players invest heavily in advanced stent graft systems, imaging-guided procedures, and global market expansion, the future of aortic aneurysm management promises improved patient outcomes, broader access to life-saving treatments, and sustained global market expansion well into 2032.

Read More Related Reports:

Genetic Toxicology Testing Market https://www.persistencemarketresearch.com/market-research/genetic-toxicology-testing-market.asp
In-vitro Toxicology Assays Market https://www.persistencemarketresearch.com/market-research/in-vitro-toxicology-assays-market.asp
Telestroke Services Market https://www.persistencemarketresearch.com/market-research/telestroke-services-market.asp
Non-Emergency Medical Transportation Market https://www.persistencemarketresearch.com/market-research/non-emergency-medical-transportation-market.asp

Contact Us:

Persistence Market Research
Second Floor, 150 Fleet Street, London, EC4A 2DQ, United Kingdom
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.